Media Summary: Lonza experts Selene Araya and Charles Johnson discuss the manufacturing process, trends, and future of highly potent ... Adeline Siew Scientific Editor of Pharmaceutical Technology and Pharmaceutical Technology Europe talks to Joe Galati, Manager ... Martin Meeson, CEO, and Arul Ramadurai, CCO, discuss Axplora's investments in GLP-1, ADC and
A View On Hpapis - Detailed Analysis & Overview
Lonza experts Selene Araya and Charles Johnson discuss the manufacturing process, trends, and future of highly potent ... Adeline Siew Scientific Editor of Pharmaceutical Technology and Pharmaceutical Technology Europe talks to Joe Galati, Manager ... Martin Meeson, CEO, and Arul Ramadurai, CCO, discuss Axplora's investments in GLP-1, ADC and Hear from a company that has deep experience in scale-up and commercial manufacturing of complex, high-potent API's derived ... Adeline Siew Scientific Editor of Pharmaceutical Technology and Pharmaceutical Technology Europe talks to Jeff Dinyer, Director ... Watch the full video at: www.nuvisan.com/videolibrary In this talk, we discussed the specific challenges associated with the ...
The rise of high-potent active pharmaceutical ingredients ( Join our Senior Director of Technical Operations at Germantown, as he discusses how to choose an outsourced partner for ...
![[Nuvisan Talk] How to overcome the challenges of HPAPI in chemical development](https://i.ytimg.com/vi/yIIglLTTdYs/mqdefault.jpg)
